Skip to content
Screener

Shattuck Labs, Inc. STTK Net Change in Cash

Net Change in Cash at other companies

Eli Lilly logo
Eli LillyLLY
$3.67B+1,196%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$1.98B-86.2%
Amgen logo
AmgenAMGN
$1.95B+349%
AbbVie logo
AbbVieABBV
$4.16B+1,293%
Aclaris Therapeutics logo
Aclaris TherapeuticsACRS
-$9.49M
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
$60.3M+173%

Other financials

Income statement

See full
Revenue-
Operating income-$16.2M-24.0%
Net income-$15.2M-21.6%
EPS (diluted)-$0.12+50.0%

Balance sheet

See full
Cash & equivalents$63.3M+25.4%
Total debt$2.7M-10.0%
Total equity$211.1M+270%
Total assets$220.7M+243%

Cash flow

See full
Operating cash flow-$10.2M+2.4%
CapEx$78.0K
Free cash flow-$10.3M+1.6%

Valuation

See full
Market cap$681.93M+1,826%
Enterprise value$621.3M-5,241%
P/S681.9×+670×

Profitability

See full
Operating margin-5,578.7%-15,316pp
Net margin-5,256.8%-14,625pp
FCF margin-4,124%-23,818pp

Returns & leverage

See full
Return on equity-39.2%-12.5pp
Debt / equity0.0×
Current ratio27.6×+17.3×

Where this comes from

Reported directly by Shattuck Labs, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The source filing: Shattuck Labs, Inc.’s 10-Q, filed May 7, 2026.

Filed
May 7, 2026, 6:54 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001628280-26-031661
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Proceeds from the exercises of stock options and purchases pursuant to employee stock purchase plan598
Taxes paid related to net share settlement of equity awards(262)(65)
Net cash provided by (used in) financing activities25,803(57)
Increase in cash and cash equivalents36,2273,511
Cash and cash equivalents, beginning of period54,19257,387
Cash and cash equivalents, end of period$90,419$60,898
Supplemental disclosures of non-cash financial activities:
Unrealized gain on investments$6

Item 1. Condensed Financial Statements (Unaudited)

FAQ

What is Shattuck Labs, Inc.'s net change in cash?
Shattuck Labs, Inc. (STTK) reported net change in cash of $36.23M in Q1 2026.
How has Shattuck Labs, Inc.'s net change in cash changed year-over-year?
Shattuck Labs, Inc.'s net change in cash increased by 931.8% year-over-year, from $3.51M to $36.23M.
What does net change in cash mean?
Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.

Ask your AI about Shattuck Labs, Inc.'s net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude